Please provide answers, thank you. #CASE STUDY II Colorectal Cancer…

Question Answered step-by-step Please provide answers, thank you. #CASE STUDY II Colorectal Cancer… Please provide answers, thank you.#CASE STUDY IIColorectal CancerUninsured patients with colorectal cancer have a greater risk of dying than do patients with private indemnity insurance, even after adjusting for differences in the stage at which the cancer is diagnosed and the treatment modality. Using the Florida cancer registry for 1994, Roetzheim and colleagues (1999) analyzed the relative likelihood of late-stage diagnosis by insurance status for more than 8,000 cases of colorectal cancer. In a multivariable analysis adjusting for sociodemographic characteristics, smoking status, and comorbidities, uninsured patients were more likely to be diagnosed with late-stage colorectal cancer than were patients with private indemnity coverage (OR = 1.67). Medicaid enrollees had a statistically insignificant greater likelihood of late-stage disease compared to patients with indemnity coverage (OR = 1.44, CI: 0.92-2.25).A subsequent analysis of largely the same data set (9,500 cases) that adjusted for sociodemographic factors and comorbidities but not for smoking estimated the adjusted mortality risk for uninsured patients with colorectal cancer to be 64 percent greater over a three- to four-year follow-up period than that for patients covered by private indemnity plans (Roetzheim et al., 2000b).5 Even after adjusting for stage of disease at diagnosis, the risk of death for uninsured patients was 50 percent higher than that for the privately insured, and after further adjustment for treatment modality, the risk for uninsured patients was 40 percent higher (Roetzheim et al., 2000b).Prostate CancerIn addition to delayed diagnosis and greater risk of death, uninsured prostate cancer patients have been found to experience a decrease in health-related quality of life after their diagnosis and during treatment, unlike publicly and privately insured patients. A study of about 8,700 cases of newly diagnosed prostate cancer reported to the Florida cancer registry in 1994 found that uninsured men were more likely to be diagnosed at a late stage of the disease than were men with private indemnity insurance (OR = 1.47) (Roetzheim et al., 1999). A study of 860 men in 26 medical practices with newly diagnosed prostate cancer evaluated their health-related quality of life (HRQOL) at three- to six-month intervals over a two-year period (Penson et al., 2001). Although uninsured men diagnosed with prostate cancer did not have a lower HRQOL at diagnosis, their HRQOL decreased over the course of their disease and treatment, in contrast to that of HMO and Medicare patients. The authors suggest that “patients undergoing aggressive treatment, which can itself have deleterious effects on quality of life, are exposed to further hardships when they do not have comprehensive health insurance upon which to support their care”.CASE STUDY IIThe anticipated increase in health care costs and inequities12 in access to the benefits of our health system should stimulate vigorous dialogue regarding solutions. Rebalancing the investment portfolio to emphasize health protection and prevention of those conditions with high burden and cost is a logical strategy.13 However, successful efforts require developing and validating better measures of the public’s health and associated costs to guide rational decisions about the allocation of limited resources.11.________ refers to the constraint enzyme applied in cutting the ________ constituents which are methylated.12.What can trigger a significant effect on the triple-dimensional arrangement? What else can it cause on its function? Which chain won’t encounter any alterations?13.Why is it recommendable to incapacitate endogenous genes I organisms frequently?14.What is produced by both individual organisms and methodical mutagenesis programs. 15.In genetic engineering, for __________ alteration, the focal code is __________ reunification to substitute the __________ chromosomal replica of a genetic material with the __________ gene.16.Identify the impact of a selectable indicator in a scenario where the gene to be modified is replicated and a selectable indicator is interleaved? What should be the nature of the selectable indicator?17.In which nature should the altered gene which is excised from the vector and introduced into the target organism be?18.Validate the statement below.Double crossover over the flanking sequence and their chromosomal complements triggers the indicator’s incorporation into the chromosome to trigger steady attainment of the indicator.19.Basing on data from genetics, provided ________ gene is present, then it is definite that double ________ may dispense ________ replica within the chromosome.20. Justify the impact on the duplicate genes hosted in a target organism with more than one replica.21.How many GC bases are present within the CpG islands basically? How does the identity CpG islands transpire? Health Science Science Nursing Share QuestionEmailCopy link Comments (0)